Niclas E. Bengtsson

1.6k total citations · 1 hit paper
19 papers, 1.1k citations indexed

About

Niclas E. Bengtsson is a scholar working on Molecular Biology, Genetics and Biomedical Engineering. According to data from OpenAlex, Niclas E. Bengtsson has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Genetics and 5 papers in Biomedical Engineering. Recurrent topics in Niclas E. Bengtsson's work include Virus-based gene therapy research (9 papers), Muscle Physiology and Disorders (8 papers) and CRISPR and Genetic Engineering (4 papers). Niclas E. Bengtsson is often cited by papers focused on Virus-based gene therapy research (9 papers), Muscle Physiology and Disorders (8 papers) and CRISPR and Genetic Engineering (4 papers). Niclas E. Bengtsson collaborates with scholars based in United States, Switzerland and Canada. Niclas E. Bengtsson's co-authors include Jeffrey S. Chamberlain, Stephen D. Hauschka, John K. Hall, Guy L. Odom, Colin Andrus, Joel R. Chamberlain, Michael Phelps, R. David Hawkins, Edward W. Scott and Glenn A. Walter and has published in prestigious journals such as Nature Communications, PLoS ONE and Biomaterials.

In The Last Decade

Niclas E. Bengtsson

19 papers receiving 1.1k citations

Hit Papers

High levels of AAV vector integration into CRISPR-induced... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers

Niclas E. Bengtsson
Hushan Yuan United States
Jonathan Yen United States
Kathleen J. Doane United States
Hunter H. Chen United States
Amer F. Saleh United Kingdom
Renee C. Ryals United States
Mary Wang United States
Niclas E. Bengtsson
Citations per year, relative to Niclas E. Bengtsson Niclas E. Bengtsson (= 1×) peers Jennifer M. Dyson

Countries citing papers authored by Niclas E. Bengtsson

Since Specialization
Citations

This map shows the geographic impact of Niclas E. Bengtsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niclas E. Bengtsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niclas E. Bengtsson more than expected).

Fields of papers citing papers by Niclas E. Bengtsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niclas E. Bengtsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niclas E. Bengtsson. The network helps show where Niclas E. Bengtsson may publish in the future.

Co-authorship network of co-authors of Niclas E. Bengtsson

This figure shows the co-authorship network connecting the top 25 collaborators of Niclas E. Bengtsson. A scholar is included among the top collaborators of Niclas E. Bengtsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niclas E. Bengtsson. Niclas E. Bengtsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bengtsson, Niclas E., Hichem Tasfaout, & Jeffrey S. Chamberlain. (2025). The road toward AAV-mediated gene therapy of Duchenne muscular dystrophy. Molecular Therapy. 33(5). 2035–2051. 4 indexed citations
2.
Bengtsson, Niclas E., Julie M. Crudele, Jordan M. Klaiman, et al.. (2022). Comparison of dystrophin expression following gene editing and gene replacement in an aged preclinical DMD animal model. Molecular Therapy. 30(6). 2176–2185. 9 indexed citations
3.
Bengtsson, Niclas E., Hichem Tasfaout, Stephen D. Hauschka, & Jeffrey S. Chamberlain. (2020). Dystrophin Gene-Editing Stability Is Dependent on Dystrophin Levels in Skeletal but Not Cardiac Muscles. Molecular Therapy. 29(3). 1070–1085. 22 indexed citations
4.
Ramos, Julian N., Katrin Hollinger, Niclas E. Bengtsson, et al.. (2019). Development of Novel Micro-dystrophins with Enhanced Functionality. Molecular Therapy. 27(3). 623–635. 79 indexed citations
5.
Hanlon, Killian S., Benjamin P. Kleinstiver, Sara P. Garcia, et al.. (2019). High levels of AAV vector integration into CRISPR-induced DNA breaks. Nature Communications. 10(1). 4439–4439. 289 indexed citations breakdown →
6.
Vohra, Ravneet, et al.. (2018). Non-invasive tracking of disease progression in young dystrophic muscles using multi-parametric MRI at 14T. PLoS ONE. 13(10). e0206323–e0206323. 7 indexed citations
7.
Bengtsson, Niclas E., John K. Hall, Guy L. Odom, et al.. (2017). Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nature Communications. 8(1). 14454–14454. 305 indexed citations
8.
Lee, Choong H., et al.. (2017). Magnetic Resonance Microscopy (MRM) of Single Mammalian Myofibers and Myonuclei. Scientific Reports. 7(1). 39496–39496. 8 indexed citations
9.
Bengtsson, Niclas E., Jane T. Seto, John K. Hall, Jeffrey S. Chamberlain, & Guy L. Odom. (2015). Progress and prospects of gene therapy clinical trials for the muscular dystrophies. Human Molecular Genetics. 25(R1). R9–R17. 50 indexed citations
10.
Bengtsson, Niclas E., et al.. (2015). Solar Water Pumping for Irrigation : Case Study of the Kilimanjaro Region. KTH Publication Database DiVA (KTH Royal Institute of Technology). 2 indexed citations
11.
Seto, Jane T., Niclas E. Bengtsson, & Jeffrey S. Chamberlain. (2014). Therapy of Genetic Disorders: Novel Therapies for Duchenne Muscular Dystrophy. Current Pediatrics Reports. 2(2). 102–112. 26 indexed citations
12.
Sharma, Parvesh, Niclas E. Bengtsson, Glenn A. Walter, et al.. (2012). Gadolinium‐Doped Silica Nanoparticles Encapsulating Indocyanine Green for Near Infrared and Magnetic Resonance Imaging. Small. 8(18). 2856–2868. 63 indexed citations
13.
Hazra, Sugata, Yagna Jarajapu, Sergio Caballero, et al.. (2012). Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model. Diabetologia. 56(3). 644–653. 66 indexed citations
14.
Mitra, Rajendra Narayan, Xiaolei Zhang, Niclas E. Bengtsson, et al.. (2011). An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug delivery. Biomaterials. 33(5). 1500–1508. 48 indexed citations
15.
Tallury, Padmavathy, Swadeshmukul Santra, Parvesh Sharma, et al.. (2011). Fluorescent and Paramagnetic Chitosan Nanoparticles that Exhibit High Magnetic Resonance Relaxivity: Synthesis, Characterization and <I>In Vitro</I> Studies. Journal of Biomedical Nanotechnology. 7(5). 724–729. 11 indexed citations
16.
Bengtsson, Niclas E., Sang‐Woo Kim, Lin Li, Glenn A. Walter, & Edward W. Scott. (2011). Ultra-high-field MRI real-time imaging of HSC engraftment of the bone marrow niche. Leukemia. 25(8). 1223–1231. 19 indexed citations
17.
Sharma, Parvesh, Scott C. Brown, Niclas E. Bengtsson, et al.. (2010). Multimodal Nanoparticulate Bioimaging Contrast Agents. Methods in molecular biology. 624. 67–81. 33 indexed citations
18.
Bengtsson, Niclas E., et al.. (2010). lacZ as a genetic reporter for real-time MRI. Magnetic Resonance in Medicine. 63(3). 745–753. 30 indexed citations
19.
Sharma, Parvesh, Scott C. Brown, Niclas E. Bengtsson, et al.. (2008). Gold-Speckled Multimodal Nanoparticles for Noninvasive Bioimaging. Chemistry of Materials. 20(19). 6087–6094. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026